A type of immunotherapy used to block proteins (CTLA-4, PD-1, and PD-L1) that stop the immune system from attacking cancer cells.
A type of immunotherapy used to block proteins (CTLA-4, PD-1, and PD-L1) that stop the immune system from attacking cancer cells.